Thurston Springer Miller Herd & Titak’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4K Hold
105
0.01% 590
2026
Q1
$28K Hold
105
0.01% 681
2025
Q4
$26.3K Buy
+105
New +$27.9K 0.01% 652
2025
Q3
Sell
-101
Closed -$26.5K 1015
2025
Q2
$26.5K Hold
101
﹤0.01% 849
2025
Q1
$23.5K Hold
101
﹤0.01% 830
2024
Q4
$23.2K Hold
101
﹤0.01% 692
2024
Q3
$22.6K Hold
101
0.01% 786
2024
Q2
$20.6K Buy
+101
New +$20.5K 0.01% 803

Other funds holding LH

Thurston Springer Miller Herd & Titak's LH Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Labcorp (LH) position steady in Q2 2026 at 105 shares worth $29.4K. The position accounts for 0.01% of the portfolio, ranked #590.

Thurston Springer Miller Herd & Titak first reported a position in LH in Q2 2024 and has held it in 8 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 105 shares of Labcorp worth $29.4K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #590 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Labcorp in Q2 2024 and has held it in 8 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.